Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Kaiser Permanente
Context Therapeutics Inc.
BioNTech SE
Jonsson Comprehensive Cancer Center
West China Hospital
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Seagen Inc.
Astellas Pharma Inc
Second Affiliated Hospital of Guangzhou Medical University
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Children's Oncology Group
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
City of Hope Medical Center
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
UNICANCER
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
AHS Cancer Control Alberta
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida